glp-1 + b12 longevity microdose What is Microdosing for weight loss – THS Blog Microdosing GLP-1s: Risks & Considerations

Punchline: From a single breakthrough to a scalable platform, GLP-1s have redefined Lillys business, positioning the company at the center of a new metabolic category.

This interview has been edited and condensed for clarity .

But our journey toward building the portfolio of safe small molecule oral longevity therapeutics is just beginning

The ADA's 2024 Standards of Care states: "There is no additional glycemic benefit to combining a DPP-4 inhibitor with a GLP-1 receptor agonist, and the combination is not recommended" [16]

Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: a randomized clinical trial